COLLEEN MEISER: Open Payments
NPI 1477729812 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 24 payments from 15 companies in 2025. Trend: 2023 $667 · 2024 $275 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $110 |
| Corcept Therapeutics | 3 | $70 |
| Novo Nordisk Inc | 2 | $53 |
| Insulet Corporation | 1 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Sequel Med Tech, LLC | 1 | $31 |
| Medtronic, Inc. | 1 | $30 |
| Amgen Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: MOUNJARO, Korlym, Wegovy, Omnipod, LEQVIO, Kerendia, TWIIST, INPEN SMART INSULIN DELIVERY SYSTEM.
Industry payments across VA — which companies pay providers there.
